Nuveen Asset Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,315
| Closed | -$197K | – | 3319 |
|
|
2023
Q3 | $197K | Buy |
5,315
+2,766
| +109% | +$102K | ﹤0.01% | 3043 |
|
|
2023
Q2 | $103K | Sell |
2,549
-63,935
| -96% | -$2.57M | ﹤0.01% | 3151 |
|
|
2023
Q1 | $4.82M | Buy |
66,484
+15,490
| +30% | +$1.12M | ﹤0.01% | 1912 |
|
|
2022
Q4 | $4.18M | Buy |
50,994
+30,094
| +144% | +$2.47M | ﹤0.01% | 2014 |
|
|
2022
Q3 | $1.98M | Buy |
20,900
+43
| +0.2% | +$4.06K | ﹤0.01% | 2411 |
|
|
2022
Q2 | $4.06M | Sell |
20,857
-21,750
| -51% | -$4.24M | ﹤0.01% | 2086 |
|
|
2022
Q1 | $10M | Sell |
42,607
-3,811
| -8% | -$897K | ﹤0.01% | 1636 |
|
|
2021
Q4 | $18.3M | Buy |
46,418
+3,988
| +9% | +$1.57M | 0.01% | 1284 |
|
|
2021
Q3 | $19M | Sell |
42,430
-3,478
| -8% | -$1.56M | 0.01% | 1305 |
|
|
2021
Q2 | $17.8M | Buy |
45,908
+1,056
| +2% | +$411K | 0.01% | 1463 |
|
|
2021
Q1 | $16.1M | Buy |
44,852
+3,438
| +8% | +$1.23M | 0.01% | 1477 |
|
|
2020
Q4 | $20.3M | Buy |
41,414
+9,945
| +32% | +$4.88M | 0.01% | 1258 |
|
|
2020
Q3 | $10.2M | Buy |
31,469
+15,018
| +91% | +$4.87M | ﹤0.01% | 1506 |
|
|
2020
Q2 | $5.99M | Buy |
16,451
+229
| +1% | +$83.4K | ﹤0.01% | 1801 |
|
|
2020
Q1 | $3.45M | Buy |
16,222
+4,519
| +39% | +$961K | ﹤0.01% | 1908 |
|
|
2019
Q4 | $4.82M | Buy |
11,703
+2,702
| +30% | +$1.11M | ﹤0.01% | 2021 |
|
|
2019
Q3 | $3.18M | Buy |
9,001
+1,033
| +13% | +$365K | ﹤0.01% | 2186 |
|
|
2019
Q2 | $4.01M | Buy |
+7,968
| New | +$4.01M | ﹤0.01% | 2102 |
|